- Country: USA
- Summary: Purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform which contains over 120 disease markers
- UST Ref No: 125880422
- Deadline: 12 Sep 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N95025Q04811
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
Title: Purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform which contains over 120 disease markers.
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued.
(ii) The solicitation number is RFQ 75N95025Q04811 and the solicitation is issued as a Request For Quotation (RFQ).
This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; FAR Subpart 13.5—Simplified Procedures for Certain Commercial Items; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold.
THIS IS A COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER ON A BRAND-NAME BASIS WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION.
The National Institute on Drug Abuse (NIDA), Office of Acquisitions (OA), on behalf of the National Institute on Aging (NIA) intends to negotiate and award a Purchase Order for a Brand-Name product without providing for full and open competition.
NULISAseq CNS Disease Panel 120 Kit (Catalog 800104)This acquisition is conducted as non-competitive for a commercial item or service and is conducted under the authority of the FAR Subpart 13.5—Simplified Procedures for Certain Commercial Items and 13.501 Special documentation requirements and the authority of 41 U.S.C. 1901.
Pursuant to FAR Subpart 13.501 (a) (1) (iii) the justification (excluding brand name) will be made available within 14 days after contract award or in the case of unusual and compelling urgency within 30 days after contract award.
Pursuant to FAR Subpart 13.501 (a) (1) (iv) the rationale for the bra... - Documents:
Attachment-3-Invoicing-Instructions-IPP.pdf
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPurchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform which contains over 120 disease markers - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH, a Government sector organization in USA, has announced a new tender for Purchase three (3) 120 CNS kits to be measured on the Alamar Nulisa platform which contains over 120 disease markers. This tender is published on USARFP under UST Ref No: 125880422 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-09-12.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
